688767 博拓生物
2026/03 - 三个月2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-0.4322.0617.0274.28433.144
总资产报酬率 ROA (%)-0.4061.9166.5433.99929.852
投入资产回报率 ROIC (%)-0.4292.0516.9424.18932.497

边际利润分析
销售毛利率 (%)47.55746.03252.84250.33153.461
营业利润率 (%)-16.38311.27834.57426.42448.094
息税前利润/营业总收入 (%)-4.6247.60224.1056.81239.663
净利润/营业总收入 (%)-11.78410.51929.81323.81840.689

收益指标分析
经营活动净收益/利润总额(%)101.37165.119101.594123.529105.381
价值变动净收益/利润总额(%)6.5778.6343.6162.9171.647
营业外收支净额/利润总额(%)-1.519-1.6970.776-0.817-1.380

偿债能力分析
流动比率 (X)14.11210.51710.51413.96613.066
速动比率 (X)13.47210.07610.10313.30112.275
资产负债率 (%)4.8976.6227.2936.1576.879
带息债务/全部投入资本 (%)0.1020.229-0.1381.6831.666
股东权益/带息债务 (%)97,491.70543,456.457-72,239.2305,818.7475,859.963
股东权益/负债合计 (%)1,939.0591,409.1791,269.5761,520.7341,353.085
利息保障倍数 (X)-0.402-2.180-2.245-0.351-5.100

营运能力分析
应收账款周转天数 (天)88.78175.06551.27441.00417.585
存货周转天数 (天)135.764106.519117.856192.23956.333